illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. SK Biopharmaceuticals
Company logo

SK Biopharmaceuticals | Sustainability Performance

https://www.skbp.com/eng.do

Develops pharmaceutical compounds and therapies. Offers research and development, clinical trials, and production services. Supports medical and healthcare sectors with regulatory compliance, technical expertise, and operational management.

1993

South Korea

201 - 500 employees

Pharmaceuticals

$100M - 500M in revenue

$100M - 500M in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#3024
Overallⓘ
#47
in South Koreaⓘ
#75
in Pharmaceuticalsⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

262 out of 287

Overview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementAir & land impactNature and biodiversity
Social
Diversity and InclusionPay GapsExternalities
Governance
SDG Impact
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Suheung

South Korea, Health Care, Pharmaceuticals

Company logo
Shinpoong Pharm

South Korea, Health Care, Pharmaceuticals

Company logo
Celltrion

South Korea, Health Care, Pharmaceuticals

Renewable energy ⓘProportion of the company's total energy consumption sourced from renewable sources, expressed as a percentage.
26%2024
Laggard
Waste generated ⓘTotal waste generated through the company's direct operations, including both hazardous and non-hazardous materials.
26.0tonnes, 2024
Leading
Female employees ⓘProportion of women in the company's total workforce, expressed as a percentage.
53%2024
Leading
Externalities ⓘThe monetized estimate of environmental and social impacts caused by an organization that are not reflected in its financial accounts.
61.0K$, 2024
Laggard
Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
6.9T$, 2026▲5% YoY
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
547.6B$, 2024▼35.2% YoY
R&D intensity ⓘResearch and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.
28.6%2024

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available
image report
Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

Total sustainability employees

2-3

ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.

    Available in
    Scale package

    Access
  • Email
  • Email